Pioneering Reimbursement Strategies for High-Calcified Lesion Treatment

Our comprehensive reimbursement feasibility strategy focuses on advancing innovative treatments for highly calcified lesions while minimizing soft tissue trauma. Incorporating meticulous methodologies, we successfully crafted effective reimbursement strategies for this ) therapy. Our step-by-step approach mirrors industry best practices and is tailored to ensure a comprehensive understanding and successful implementation of reimbursement pathways:

Navigating the Reimbursement Landscape: Strategizing Access to Innovative Care

Our proposal extends to our client, offering a holistic understanding of reimbursement landscapes across France, the Netherlands, Belgium, Italy, Sweden, Denmark, and Norway. Our proposal outlines a reimbursement feasibility study with subsequent operational phases tailored for each country.

• Product Coding and Payment Scheme
• Coverage of Product Procedure or similar procedure
• Current guidelines for the treatment of highly calcified lesions
•  Process for creation of a new reimbursement code
• Innovative Technology Reimbursement Programs Applicability
• Clinical and Economic Evidence Requirements (Short- and Long-Term)
• HTA-Centric Clinical Value Proposition
• Short- and long-term reimbursement strategies
• Country Prioritization

Analyzing Clinical and Economic Benefits: 

Our strategic journey commences with an in-depth exploration of the existing management of patients with highly calcified lesions. We analyze how treatment protocols are reimbursed across targeted countries, which forms the bedrock of our reimbursement feasibility assessment.

Holistic Approach to Reimbursement: 

We critically review comprehensive clinical evidence encompassing completed, ongoing, and planned studies. This diligent analysis guides us in positioning this new therapy in therapeutic disease management and the necessary requisites for successful reimbursement.

Engagement with Authorities and KOLs: 

We actively engage with healthcare authorities and key opinion leaders (KOLs), understanding their perspectives and expectations. This proactive approach ensures that strategies resonate with the nuanced expectations of influential stakeholders.

Tailored Reimbursement Strategies:

 Our solution echoes best-in-class practices and includes:

• Applicable Reimbursement Scheme Analysis
• Coding and coverage information
• Specific Clinical Evidence Prerequisites for Short- and Long-Term
• Structured, actionable steps and timelines for reimbursement implementation
• Strategic Roadmap Prioritizing Countries and Offering Informed Recommendations